Search

Publications

Ruxolitinib for the management of myelofibrosis: Results of an international physician survey. Ellis MH, Koren-Michowitz M, Lavi N, Vannucchi AM, Mesa R, Harrison CN. Leuk Res. 2017 Oct;61:6-9. doi: 10. 1016/j. leukres. 2017. 08. 002.

SWG Education Activities

Session at EHA2023The EHA2023 Congress was held in Frankfurt in June 2023. During the event, we held a session with the EHA Adolescent and Young Adult (AYA) Taskforce on the treatment of AYA patients with acute lymphoblastic leukaemia (ALL).

EHA-EMBL/EBI Computational Biology Training in Hematology

The CBTH 2025 call for applications is now closed.

Advocacy priorities

The European Union works on countless pieces of legislation and policies that affect the health ecosystem. Some are relevant to most medical disciplines, including hematology—such as the legislation on health data or pharmaceuticals.

Presidential Speakers

Promising crucial developments in the field of hematology, the speakers and presentation topics of the EHA2025 Presidential Session speakers are now available.

Friday, June 13, 2025 - Presidential Session I

Immunotherapy (TCR related)

Prof.

Meeting program

Friday, April 25 - EHA-Balkan Hematology Day 202509:00 - 10:10 CEST Opening remarks & special lecture

Welcome of participants
Dimitar Efremov (Italy)
Welcome and introduction of meeting program
Irina Panovska-Stavridis (North Macedonia)
EHA and History of Balkan Hematology Day
Gianluca Gaidano (Italy)
History of the Balkan Hematology…

Grants & abstract awards

EHA Travel GrantsThe call for travel grant applications closed on March 1, 2025 (23:59 CET). The grants will only be available for investigators with accepted abstracts, submitted during the regular abstract submission.